Dr. Nav Malhi presented the RHAPSODY Trial, which is a phase 3, multicenter, double-blind, event-driven, randomized-withdrawal trial of rilonacept in patients with acute symptoms of recurrent pericarditis and systemic inflammation.…
VanSCAD conference will be held virtually this year on Jan 30, 2021 due to the COVID-19 pandemic. An international team of SCAD experts will be on faculty to provide a contemporary update…
Watch this session presented by Victoria Delgado, with the participation of Philip McCarthy, Dee Dee Wang and David Wood each presenting their findings regarding role and limitations of echocardiography in…
BACKGROUND Guidelines recommend a trial of one or more antiarrhythmic drugs before catheter ablation is considered in patients with atrial fibrillation. However, first-line ablation may be more effective in maintaining…
Contemporary cardiac intensive care units (CICUs) have an increasing prevalence of noncardiovascular comorbidities and multisystem organ dysfunction. However, little guidance exists to support the development of best-practice principles specific to…
Dr. Lisa Tang and CCI Investigator Dr. Jason Andrade used machine learning with daily heart rhythm data to predict outcomes after ablation for atrial fibrillation (AF). Data were analysed from…
Many physicians have long believed that maintaining patients in sinus rhythm is beneficial in A-fib. Finally: a win—with caveats. Commenting on the study, Jason Andrade, MD (Vancouver General Hospital, Canada),…
Use of a minimalist approach that facilitates early discharge is even more important in the COVID-19 era, experts say. Discharging patients within 24 hours of a transfemoral TAVR procedure performed…